Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Allen Ziegler, Katie L.
93  Ergebnisse:
Personensuche X
?
1

Impact of disease progression date determination on progres..:

Qi, Yingwei ; Allen Ziegler, Katie L. ; Hillman, Shauna L....
Cancer.  118 (2012)  21 - p. 5358-5365 , 2012
Link: https://doi.org/10.1002/..
 
?
2

Sa1864 Aspirin Downregulates Cell Survival and mTOR Effecto..:

Buttar, Navtej ; Falk, Gary W. ; Sharma, Anamay N....
Gastroenterology.  146 (2014)  5 - p. S-315 , 2014
Link: https://doi.org/10.1016/..
 
?
3

Population Pharmacokinetic Model for Cancer Chemoprevention..:

Berg, Alexander K. ; Mandrekar, Sumithra J. ; Ziegler, Katie L. Allen...
The Journal of Clinical Pharmacology.  53 (2013)  4 - p. 403-412 , 2013
Link: https://doi.org/10.1002/..
 
?
4

Randomized phase II trial of sulindac for lung cancer chemo..:

Limburg, Paul J. ; Mandrekar, Sumithra J. ; Aubry, Marie Christine...
Lung Cancer.  79 (2013)  3 - p. 254-261 , 2013
Link: https://doi.org/10.1016/..
 
?
5

A Combination of Esomeprazole and Aspirin Reduces Tissue Co..:

Falk, Gary W. ; Buttar, Navtej S. ; Foster, Nathan R....
Gastroenterology.  143 (2012)  4 - p. 917-926.e1 , 2012
Link: https://doi.org/10.1053/..
 
?
6

883 Characteristics Associated With Rectal Aberrant Crypt F..:

Limburg, Paul J. ; Mahoney, Michelle R. ; Ziegler, Katie Allen...
Gastroenterology.  142 (2012)  5 - p. S-153 , 2012
Link: https://doi.org/10.1016/..
 
?
7

Phase II trial of lapatinib and topotecan (LapTop) in patie..:

Weroha, S. John ; Oberg, Ann L. ; Ziegler, Katie L. Allen...
Gynecologic Oncology.  122 (2011)  1 - p. 116-120 , 2011
Link: https://doi.org/10.1016/..
 
?
8

M1195 Phase II Chemoprevention Trial of Atorvastatin (ATOR)..:

Limburg, Paul J. ; Mahoney, Michelle R. ; Ziegler, Katie Allen...
Gastroenterology.  138 (2010)  5 - p. S-352 , 2010
Link: https://doi.org/10.1016/..
 
?
9

A Phase II Study of Pazopanib in Patients with Malignant Pl..:

Parikh, Kaushal ; Mandrekar, Sumithra J. ; Allen-Ziegler, Katie...
The Oncologist.  25 (2019)  6 - p. 523-531 , 2019
Link: https://doi.org/10.1634/..
 
?
10

A Randomized Phase IIb Trial of myo-Inositol in Smokers wit..:

Lam, Stephen ; Mandrekar, Sumithra J ; Gesthalter, Yaron...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136333/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
11

Phase 0 Clinical Chemoprevention Trial of the AKT Inhibitor..:

Reid, Joel M ; Walden, Chad ; Qin, Rui...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061470.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
12

Randomized Phase II Trial of Sulindac, Atorvastatin and Pre..:

Limburg, Paul J ; Mahoney, Michelle R ; Allen Ziegler, Katie L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046804.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
13

Correlation Between Polymorphisms of the Reduced Folate Car..:

Adjei, Araba A ; Salavaggione, Oreste E ; Mandrekar, Sumithra J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735419/.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
14

Endpoints in Phase II trials for advanced non-small cell lu..:

Mandrekar, Sumithra J ; Qi, Yingwei ; Hillman, Shauna L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798014.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
15

Evaluation of Glutathione Metabolic Genes on Outcomes in Ad..:

Yang, Ping ; Mandrekar, Sumithra J ; Hillman, Shauna H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998042.  , 2009
Link: http://www.ncbi.nlm.nih...
 
1-15